EMA Launches Regulatory Roadmap to Address Gender Disparities in Clinical Trial Design

The European Medicines Agency (EMA) has announced a new regulatory roadmap aimed at reforming clinical research and trial designs. This initiative seeks to improve representation and generate data more relevant to women's health, ensuring that clinical evidence better serves all patients. The commitment follows a multi-stakeholder workshop.